News
1mon
StudyFinds on MSNBreakthrough blood test could transform ALS diagnosis, careThe researchers tested four technologies for measuring NfL: Simoa, Ella, Lumipulse ... The study demonstrates that serum NfL ...
Four serum neurofilament light chain (NfL ... a head-to-head comparison of four technologies for NfL measurement: Ultrasensitive Simoa, microfluidic Ella platform, and clinical-grade Lumipulse ...
“Simoa has been at the forefront of the emergence ... In 2017, Kuhle and colleagues demonstrated the relevance of serum NfL measures for multiple sclerosis (MS) 4. In addition to high ...
The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the ...
kit as part of their industry-leading Simoa ® assay kits at the International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in Vienna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results